SLV310, a novel, potential antipsychotic, combining potent dopamine D2 receptor antagonism with serotonin reuptake inhibition.
暂无分享,去创建一个
C. Kruse | M. Hesselink | A. McCreary | M. Tulp | J. A. van der Heyden | P. Smid | K. Tipker | C. Stroomer | R. van Hes